development of biomarkers for clarifying pathology and evaluating activity in pediatric immune-related diseases

development of biomarkers for clarifying pathology and evaluating activity in pediatric immune-related diseases - development of biomarkers for clarifying pathology and evaluating activity in pediatric immune-related diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023980

Enrollment

250

Registered

2016-09-08

Start date

2016-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric immune-related diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) childhood-onset immune-related disease 2) witten informed consent

Exclusion criteria

Exclusion criteria: patients judged by the investigator to be unfit to participate in the study

Design outcomes

Primary

Measure	Time frame
development biomarkers to evaluating disease activity	—

Countries

Japan

Contacts

Public ContactAyako Murase

Yokohama city university Department of Pediatrics

t206076d@yokohama-cu.ac.jp045-787-2800

Outcome results